SEC Form 5 · accession 0001214659-16-008823
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Klara Dickinson
Officer — SVP & Chief Regulatory Office
Period of report
Dec 31, 2015
Accepted (ET)
Jan 11, 2016 · 2:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2015 | A | 12,500 | $1.49 | A | 12,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 12,500 shares acquired under the Issuer's 2010 Employee Stock Purchase Plan on June 30, 2015.